Pharmacokinetic evaluation of vadimezan (ASA404, 5,6-dimethylxanthenone-4-acetic acid, DMXAA)

By Jameson Michael B   Head Michelle  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1315-1326

Informa Healthcare

Access to resources Recommend Favorite

Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

By Zhao Liangli   Marshall Elaine   Kelland Lloyd   Baguley Bruce  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 271-276

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of the action of the antivascular drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA; ASA404) by non-steroidal anti-inflammatory drugs

By Wang L.-C.   Ching Lai-Ming   Paxton James   Kestell Philip   Sutherland Rachel   Zhuang Li   Baguley Bruce  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 280-284

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacology and Function of Imidazole 4-Acetic Acid in Brain - treatment with imidazole-4-acetic acid

By Tunnicliff G.  

General Pharmacology, Vol. 31, Iss. 4, 1998-10 ,pp. : 503-509

Elsevier

Access to resources Recommend Favorite

Synthesis of 4-substituted-3-hydroxy-5-oxo-10-oxa-4-azatricyclo[5.2.1]dec- 3-yl Acetic Acid Ethyl Esters as Norcantharidin Analogues

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 1, 2009-01 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite